Synthesis route and three different core-shell impacts on magnetic characterization of gadolinium oxide-based nanoparticles as new contrast agents for molecular magnetic resonance imaging

Nanoscale Research Letters

Volumn 7, Issue , 2012, Pages 1-10

  Azizian, Gholamreza ^a   Riyahi Alam, Nader ^a   Haghgoo, Soheila ^b   Moghimi, Hamid Reza ^d   Zohdiaghdam, Reza ^a   Rafiei, Behrooz ^c   Gorji, Ensieh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DEG; Gadolinium oxide; mPEG silane; Nanomagnetic particle; Relaxivity

Indexed keywords

COATINGS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; INDUCTIVELY COUPLED PLASMA; LIGHT SCATTERING; LIGHT TRANSMISSION; MAGNETIC RESONANCE IMAGING; MAGNETOPLASMA; MOLECULAR IMAGING; NANOMAGNETICS; NANOPARTICLES; PHYSICOCHEMICAL PROPERTIES; SCANNING; SYNTHESIS (CHEMICAL);

GADOLINIUM OXIDE; MAGNETIC CHARACTERIZATION; METHOXYPOLYETHYLENE GLYCOL; NANOMAGNETIC PARTICLES; NANOPARTICLE PREPARATIONS; PHYSICO-CHEMICAL CHARACTERIZATION; RELAXIVITY; VIBRATING SAMPLE MAGNETOMETER;

GADOLINIUM COMPOUNDS;

EID: 84871027365     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-7-549     Document Type: Article

References (26)

1. Pereira GA, Geraldes CFGC: Design and optimization of gadolinium based contrast agents for magnetic resonance imaging. Ann Magn Reson 2007, 6(1):1-33.
2. Hengerer A, Grimm J: Molecular magnetic resonance imaging. Biomed Imaging Interv J 2006, 2(2):1-7.
3. Kuriashkin IV, Losonsky JM: Contrast enhancement in magnetic resonance imaging using intravenous paramagnetic contrast media: a review. Vet Radiol Ultrasound 2000, 41(1):4-7.
4. Gould P: Nanomagnetism shows in vivo potential. Nano Today 2006, 1(4):34-39.
5. Laurent S, Elst LV, Muller RN: Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Med Mol Imaging 2006, 1(3):128-137.
6. Frame EM, Uzgiris EE: Gadolinium determination in tissue samples by inductively coupled plasma mass spectrometry and inductively coupled plasma atomic emission spectrometry in evaluation of the action of magnetic resonance imaging contrast agents. Analyst 1998, 123(4):675-679.
7. McDonald MA, Watkin KL: Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles. Acad Radiol 2006, 13(4):421-427.
8. Waters EA, Wickline SA: Contrast agents for MRI. Basic Res Cardiol 2008, 103(2):114-121.
9. Pankhurst QA, Connolly J, Jones SK, Dobson J: Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 2003, 36:167-181.
10. 3nanocrystals functionalized by organic acids. J Colloid Interface Sci 2005, 228(1):140-148.
11. Engström M, Klasson A, Pedersen H, Vahlberg C, Käll PO, Uvdal K: High proton relaxivity for gadolinium oxide nanoparticles. MAGMA 2006, 19(4):180-186.
12. 3nanoparticles. Contrast Media Mol Imaging 2008, 3(3):106-111.
13. Riyahi-Alam N, Behrouzkia Z, Seifalian A, Haghgoo Jahromi S: Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles. Biol Trace Elem Res 2010, 137(3):324-334.
14. Faucher L, Gossuin Y, Hocq A, Fortin MA: Impact of agglomeration on the relaxometric properties of gadolinium oxide nanoparticles. Nanotechnology 2011, 22(29):295103.
15. Kamaly N, Pugh JA, Kalber TL, Bunch J, Miller AD, McLeod CW, Bell JD: Imaging of gadolinium spatial distribution in tumor tissue by laser ablation inductively coupled plasma mass spectrometry. Mol Imaging Biol 2010, 12(4):361-366.
16. Doiron AL, Chu K, Ali A, Brannon-Peppas L: Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI. Proc Natl Acad Sci U S A 2008, 105(45):17232-17237.
17. Schipper ML, Iyer G, Koh AL, Cheng Z, Ebenstein Y, Aharoni A, Keren S, Bentolila LA, Li J, Rao J, Chen X, Banin U, Wu AM, Sinclair R, Weiss S, Gambhir SS: Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 2009, 5(1):126-134.
18. Mulder WJ, Strijkers GJ, Briley-Saboe KC, Frias JC, Aguinaldo JG, Vucic E, Amirbekian V, Tang C, Chin PT, Nicolay K, Fayad ZA: Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. Magn Reson Med 2007, 58(6):1164-1170.
19. Oyewumia MO, Yokel RA, Jay M, Coakley T, Mumper RJ: Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control Release 2004, 95(3):613-626.
20. Nelson J, Bennett LH, Wagner MJ: Solution synthesis of gadolinium nanoparticles. J Am Chem Soc 2002, 124(12):2979-2983.
21. Fortin MA, Petoral RM, Söderlind F, Klasson A, Engström M, Veres T, Käll PO, Uvdal K: Polyethylene glycol-covered ultra-small Gd2O3 nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning. Nanotechnology 2007, 18(39):395501-395510.
22. 3nanocrystals and organic molecules-an experimental and quantum-chemical study. Surface Sci 2005, 592(1-3):124-140.
23. Wu Y, Zuo F, Zheng Z, Ding X, Peng Y: A novel approach to molecular recognition surface of magnetic nanoparticles based on host-guest effect. Nanoscale Res Lett 2009, 4(7):738-747.
24. Casula MF, Corrias A, Arosio P, Lascialfari A, Sen T, Floris P, Bruce IJ: Design of water-based ferrofluids as contrast agents for magnetic resonance imaging. J Colloid Interface Sci 2011, 357(1):50-55.
25. Casula MF, Floris P, Innocenti C, Lascialfari A, Marinone M, Corti M, Sperling R, Parak WJ, Sangregorio C: Magnetic resonance imaging contrast agents based on iron oxide superparamagnetic ferrofluids. Chem Mater 2010, 22:1739-1748.
26. Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, Zhou J, Zhu J, Gao X: PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release 2001, 71(2):203-211.